METRA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 60.833
EU - Europa 31.196
AS - Asia 15.555
AF - Africa 120
Continente sconosciuto - Info sul continente non disponibili 77
OC - Oceania 77
SA - Sud America 71
AN - Antartide 1
Totale 107.930
Nazione #
US - Stati Uniti d'America 60.663
UA - Ucraina 10.680
CN - Cina 10.252
IT - Italia 4.798
DE - Germania 4.011
PL - Polonia 3.447
HK - Hong Kong 3.312
FI - Finlandia 2.258
IE - Irlanda 1.913
GB - Regno Unito 1.711
FR - Francia 1.169
IN - India 1.137
SE - Svezia 594
TR - Turchia 306
RU - Federazione Russa 234
CA - Canada 148
VN - Vietnam 125
QA - Qatar 114
BE - Belgio 112
SG - Singapore 92
MU - Mauritius 84
EU - Europa 76
AU - Australia 70
NL - Olanda 70
JP - Giappone 38
KR - Corea 37
RO - Romania 36
ES - Italia 35
IR - Iran 35
BR - Brasile 26
ID - Indonesia 19
CH - Svizzera 18
SA - Arabia Saudita 14
GR - Grecia 13
PH - Filippine 13
AT - Austria 12
CL - Cile 11
CO - Colombia 11
AL - Albania 10
EG - Egitto 10
PK - Pakistan 10
HU - Ungheria 9
MK - Macedonia 9
SK - Slovacchia (Repubblica Slovacca) 9
TH - Thailandia 9
MX - Messico 8
AR - Argentina 7
NZ - Nuova Zelanda 7
BG - Bulgaria 6
IQ - Iraq 6
SI - Slovenia 6
VE - Venezuela 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
LA - Repubblica Popolare Democratica del Laos 5
PE - Perù 5
TN - Tunisia 5
EE - Estonia 4
IL - Israele 4
KZ - Kazakistan 4
LU - Lussemburgo 4
MA - Marocco 4
PA - Panama 4
PT - Portogallo 4
TW - Taiwan 4
UG - Uganda 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
JO - Giordania 3
LV - Lettonia 3
NO - Norvegia 3
RS - Serbia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
BS - Bahamas 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
FK - Isole Falkland (Malvinas) 2
IS - Islanda 2
KW - Kuwait 2
MY - Malesia 2
UY - Uruguay 2
A1 - Anonimo 1
BZ - Belize 1
CY - Cipro 1
EC - Ecuador 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
LK - Sri Lanka 1
MD - Moldavia 1
PR - Porto Rico 1
Totale 107.929
Città #
Fairfield 8.125
Jacksonville 7.990
Woodbridge 6.023
Houston 4.117
Ashburn 4.085
Chandler 4.080
Cambridge 3.588
Princeton 3.516
Warsaw 3.424
Wilmington 3.420
Hong Kong 3.301
Ann Arbor 3.254
Seattle 3.039
Nanjing 2.750
Dublin 1.899
Beijing 1.530
New York 1.327
Nanchang 1.033
Helsinki 970
Des Moines 802
Hebei 661
Shenyang 658
Changsha 538
San Diego 497
Tianjin 468
Milan 467
Jiaxing 446
Dearborn 375
Brescia 374
Jinan 367
Kunming 311
Kocaeli 247
Hangzhou 226
Verona 222
London 194
Shanghai 188
Rome 186
Lancaster 139
Boardman 136
Ningbo 134
Lanzhou 125
Pune 121
Dong Ket 120
Zhengzhou 119
Moscow 116
Doha 114
Taizhou 105
Brussels 102
Norwalk 102
San Francisco 100
Haikou 99
Orange 89
Toronto 77
Los Angeles 76
Changchun 75
Guangzhou 74
Fuzhou 64
Frankfurt am Main 62
Kilburn 61
Lappeenranta 59
Florence 57
Taiyuan 57
Washington 53
Saint Petersburg 49
Redwood City 48
San Mateo 47
Napoli 46
Palermo 33
Augusta 32
Chicago 32
Chiswick 31
Catania 30
Bologna 27
Phoenix 27
Melbourne 26
Bari 25
Acton 24
Naples 23
Seongnam 23
Trieste 23
Strasbourg 22
Hefei 21
Leawood 21
Prescot 21
Tokyo 21
Westminster 21
Canberra 20
Hanover 20
Ottawa 20
Padova 20
Auburn Hills 19
Caserta 19
North York 19
Pavia 19
Torino 19
Hounslow 18
Prevalle 18
Falls Church 17
Redmond 17
Ardabil 16
Totale 78.068
Nome #
Un caso di Sindrome di Bland-White-Garland: origine anomala dell’arteria coronaria sinistra dall’arteria polmonare. 633
Inodilatatori: perché e quali. 362
American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). 313
Farmaci inotropi non digitalici. 309
Effect of nesiritide in patients with acute decompensated heart failure. 294
Il genotipo DD per il gene dell’enzima di conversione dell’angiotensina identifica i pazienti con insufficienza cardiaca che possono beneficiare di dosi medio elevate di ACE inibitori. 279
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 265
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure 242
Livelli circolanti del marcatore tumorale CA 125 in pazienti con scompenso cardiaco cronico:relazione con la classe NYHA, i parametri ecocardiografici e variazioni indotte dalla terapia. 241
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 240
La cardiomioplastica dinamica come trattamento della cardiomiopatia dilatativa ingravescente. 230
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 225
Can we improve the treatment of congestion in heart failure? 211
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis 210
May 2020 at a glance: ischaemic heart failure and sex-related differences 209
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 208
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. 207
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure 206
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 206
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 203
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 200
Old and new intravenous inotropic agents in the treatment of advanced heart failure 200
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial 196
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. 195
I polimorfismi Arg16Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca 194
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European society of cardiology and endorsed by the European society of intensive care medicine 193
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study 192
Highlights of the 2009 scientific sessions of the European Society of Cardiology. 189
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. 187
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study 186
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 185
L’ indice di performance miocardica ( MPI ) è un importante indicatore prognostico nei pazienti affetti da insufficienza cardiaca cronica. 183
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. 182
Postdischarge assessment after a heart failure hospitalization: the next step forward. 182
I polimorfismi Arg16 Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca. 178
Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. 177
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. 163
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. 158
Task Force sullo Scompenso Cardiaco Acuto della Societa Europea di Cardiologia. Versione italiana a cura di A Gavazzi, M Metra. Riassunto esecutivo delle linee guida sulla diagnosi e trattamento dello scompenso cardiaco acuto. 155
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 155
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 153
Determinazione dell’equilibrio simpato-vagale attraverso l’analisi spettrale della variabilità della frequenza cardiaca in pazienti con insufficienza cardiaca di diverso grado di severità. 150
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. 147
Efficacia di un nuovo diuretico, la muzolimina, in pazienti con insufficienza cardiaca. 146
Characteristics and mid-term follow-up of a single-center population affected by Tako-Tsubo cardiomyopathy 146
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 145
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 144
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Societyof Cardiology 142
Effectiveness of MitraClip therapy in patients with refractory heart failure 142
Effects of the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure an Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A(1) Adenosine ReceptorAntagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function) 142
Effetti cardiovascolari della ventilazione servo-adattativa (ASV) in pazienti affetti da apnee notturne e scompenso cardiaco cronico con disfunzione sistolica ventricolare sinistra 141
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 141
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. 140
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 139
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 139
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 136
January 2017 at a glance: oncology, diabetes and antidiabetic treatment, pulmonary hypertension 135
Amino acids and derivatives, a new treatment of chronic heart failure? 134
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 132
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 129
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 126
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. 125
Sindromi coronariche acute: ruolo dell’infezione cronica da Helicobacter Pylori e Citomegalovirus. 123
Effects of serelaxin in patients with acute heart failure 120
Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials. 119
A drastic complex atheromatous aorta. A case report. 118
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 118
Endothelial Dysfunction And Vascular Stiffness In Women With A Previous Pregnancy Complicated By Early Or Late Preeclampsia. 116
The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction 115
Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results 115
n-3 PUFAs and cardiovascular disease prevention. 115
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 114
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 114
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 114
The puzzle of kidney dysfunction in heart failure: an introduction. 113
Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure. 112
Are Beta-1 and alpha2c-adrenergic receptor polymorphisms associated with an increased risk of heart failure in Caucasian subjects: results of a case-control study 112
Consistent survival benefit of carvedilol over metoprolol irrespective of baseline characteristics of heart failure patients – Mode of death evaluation in COMET. 111
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 111
A case of iatrogenic severe mitral regurgitation 110
Effect of High dose of atorvastatin versus moderate dose on endothelial function and inflammatory biomarkers in patients with STEMI 110
Effects of aldosterone blockers on left ventricular function and remodeling in patients with mild-moderate chronic heart failure. 109
Raised homocystein plasma concentration in patients with heart failure: Clinical significance 109
Effects of spironolactone on ventricular-arterial coupling in patients with chronic systolic heart failure and mild symptoms 109
Insights into cardiac alterations after pre-eclampsia: an echocardiographic study. 109
Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. 108
Is there a rationale for antiplatelet therapy in acute heart failure? 108
Elastic aortic properties in patients with X syndrome 108
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 108
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 108
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 107
Angiotensin-converting-enzyme gene polymorphism and heart failure: a case-control study. 107
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T 107
Neurohormonal activation in acute heart failure: results from VERITAS 107
Mechanism of cardiovascular toxicity by proteasome inhibitors: new paradigm derived from clinical and pre-clinical evidence 107
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 107
March 2019 at a glance: epidemiology and clinical trials 107
Asse cuore-rene nell’iperteso cardiopatico. 106
Acute and chronic effects of nisoldipine in patients with chronic heart failure. 106
A comparison of adverse events occurring with carvedilol or metoprolol in the treatment of heart failure: Results from COMET. 106
Totale 16.240
Categoria #
all - tutte 540.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 540.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194.159 0 0 0 0 0 0 0 0 0 0 2.123 2.036
2019/202029.569 5.441 801 966 3.301 1.384 3.237 2.347 3.233 1.866 3.631 1.227 2.135
2020/202121.566 480 2.632 518 2.690 725 2.661 1.092 2.659 3.206 2.019 2.169 715
2021/202211.535 453 2.282 230 767 247 621 378 983 646 1.315 1.114 2.499
2022/202312.159 1.998 251 133 995 1.079 3.564 46 1.195 1.745 107 505 541
2023/20249.748 752 279 742 837 525 1.818 461 472 3.490 340 32 0
Totale 109.753